USC Buys WaferGen SmartChip System for Oncology Drug Discovery | GenomeWeb

WaferGen Biosystems said today that the University of Southern California has purchased one of the company's SmartChip real-time PCR systems for use in cancer drug discovery applications.

Researchers at the USC Center for Molecular Pathways and Drug Discovery will use the SmartChip system to discover and validate biomarkers for pancreatic and colorectal cancer to expedite therapeutic development, WaferGen said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.